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background:  The new ACC/AHA cholesterol guidelines recommend consideration of statin therapy based on a 10-year risk cutoff of 7.5%. 
How guidelines affect different age and sex groups and their accuracy in predicting future events remains unknown.
Methods:  We evaluated how current guidelines affect treatment recommendations based on age and sex. The sensitivity and specificity of 
various 10-year risk cut points based on the Pooled Cohort Equations were evaluated based on incident 10-year CVD rates among 3685 
Framingham Offspring Study participants, stratified by sex and age.
Results:  The proportion of adults recommended for statins based on a 7.5% cutoff varied from 21.3% to 55.8% and 91.9% in adults aged 
40-55, 55-65 and 65-75 years; and from 31.9% to 61.2% among women and men, respectively. Sensitivity was highest, but specificity 
lowest, in men and older adults (Table). Raising the treatment threshold from 7.5% to 10% in adults aged 65-75 improved specificity (from 
11.7% to 21.6%) with little tradeoff in sensitivity (90.7% to 88.3%). Lowering the threshold from 7.5% to 4% in women improved sensitivity 
(74.8%) and specificity (54.9%) to that seen in men at the 7.5% threshold (sensitivity 73.7%, specificity 42.4%).
conclusion:  Application of age- and sex-specific treatment thresholds can improve the sensitivity and specificity of current risk prediction 
guidelines to identify adults for statin therapy.
 
